Tag: funding

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fortrea To Contact Him Directly To Discuss Their Options

SHREWSBURY, United Kingdom, July 06, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, a next-generation decentralized AI infrastructure project, has officially entered its Final Bonus Round, following the successful completion of all 15 presale stages and raising $20.9 million in token sales. This milestone reflects strong market confidence and positions the project ahead of its anticipated mainnet launch in July 2025.

Explore how online personal loan brokers like Honest Loans are transforming lending in the US with fast, flexible, and accessible financing options for 2025.

DUBAI, United Arab Emirates, July 05, 2025 (GLOBE NEWSWIRE) -- Little Pepe has surged past $3.7 million in presale funding, capturing the attention of crypto investors as one of the most promising EVM-compatible Layer 2 meme coins of 2025. Combining the viral power of meme culture with real blockchain infrastructure, the project is built on a lightning-fast, low-cost Layer 2 network designed for scalability and utility. As interest accelerates and $LILPEPE remains priced at just $0.0013 during its fourth presale stage, investors are rushing to secure their stake in what could be the next breakout star of the meme coin movement.

RadCred offers online payday loans with guaranteed approval for U.S. borrowers. Fast funding, no credit check, and flexible loan options for urgent needs.

The Egyptian construction industry is projected to grow by 6.5% in 2025, driven by increased FDI, oil and gas investments, and strong government funding. The "Construction in Egypt - Key Trends and Opportunities to 2029" report offers in-depth market analysis, highlighting growth drivers, risks, and opportunities.

Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to its research collaboration with Centessa. The milestones were achieved as Centessa initiated clinical development of ORX142, its second novel orexin receptor 2 (OX2R) agonist, following the recent clearance of an Investigational New Drug (IND) application by the US Food and Drug Administration (FDA) for a Phase 1 clinical study of ORX142 in healthy volunteers. (click here).

Honest Loans offers access to flexible online loan connections in 2025, supporting fast funding options for borrowers with less-than-perfect credit.